Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.18
+0.27 (3.91%)
At close: Oct 15, 2026, 4:00 PM EDT
7.18
0.00 (-0.04%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Emergent BioSolutions stock has a consensus rating of "Buy" and an average price target of $11. The average 1-year stock price forecast is 53.20% higher than the current stock price, while the lowest is $10 (+39.28%) and the highest is $12 (+67.13%).
Price Target: $11 (+53.20%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 9, 2026.
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +39.28% | Sep 9, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Aug 21, 2026 |
Financial Forecast
Revenue This Year
657.12M
from 742.90M
Decreased by -11.55%
Revenue Next Year
703.33M
from 657.12M
Increased by 7.03%
EPS This Year
0.36
from 1.53
Decreased by -76.50%
EPS Next Year
1.05
from 0.36
Increased by 191.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.